Literature DB >> 25693932

Association between Helicobacter pylori infection and colorectal neoplasm risk: a meta-analysis based on East Asian population.

Yu Guo1, Hai-Yan Li.   

Abstract

OBJECTIVE: The association between Helicobacter pylori (HP) infection and colorectal neoplasm risk was not clear. The aim of this study was to evaluate whether HP infection can increase the risk of developing colorectal neoplasm by meta-analysis.
MATERIALS AND METHODS: A detailed literature search was performed on Medline, PubMed, Web of Science, and China National Knowledge Infrastructure for related research publications written in English and/or Chinese. The relevant case-control or cohort studies reporting an association between HP infection and colorectal neoplasm risk were screened and included in this meta-analysis. The association between HP infection and colorectal neoplasm risk was expressed by odds ratio (OR) and its 95% confidence interval (CI). The heterogeneity among the included articles was assessed by I 2 test, and the pooled OR was calculated by fixed effect model in case of no significant heterogeneity otherwise random effect model was employed. All the statistical analyses were done by STATA-11.0 and MetaAnalyst Beta 3.13 software.
RESULTS: Finally, a total of 2081 colorectal neoplasm patients and 5598 healthy controls from nine eligible studies were included in this meta-analysis. The pooled OR for the association between HP infection and colorectal neoplasm risk was 0.18 with its 95% CI of 0.99-1.40, (P > 0.05). We further divided the colorectal neoplasm into the hyperplastic polyps, adenomas and colorectal cancer sub-groups according to colorectal neoplasm types. The pooled ORs and their 95% CIs were OR Hyperplastic_polyps = 0.72, 95% CI: 0.44-1.18, (P > 0.05), OR Adenomas = 1.83, 95% CI: 1.35-2.51, (P < 0.01), OR Colorectal_cancer = 1.08, 95% CI: 0.89-1.68 (P > 0.05). For different region sub-groups, the pooled ORs and 95% CIs were OR South_Korea = 1.18, 95% CI: 0.84-1.66, (P > 0.05), OR China = 0.78, 95% CI: 0.53-1.13, (P > 0.05), OR Taiwan = 1.06, 95% CI: 0.69-1.62, (P > 0.05), OR Japan = 1.33, 95% CI: 1.07-1.65, (P < 0.05) for South Korea, China main land, Taiwan and Japanese.
CONCLUSION: In general, no statistical association between HP infection and colorectal neoplasm risk was found in this meta-analysis. But, HP infection may increase the risk of developing colorectal adenomas.

Entities:  

Mesh:

Year:  2014        PMID: 25693932     DOI: 10.4103/0973-1482.151482

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  14 in total

Review 1.  The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.

Authors:  Jessica D Dahmus; Drew L Kotler; David M Kastenberg; C Andrew Kistler
Journal:  J Gastrointest Oncol       Date:  2018-08

2.  Correlation between Helicobacter pylori-associated gastric diseases and colorectal neoplasia.

Authors:  Ying Qing; Min Wang; Ying-Min Lin; Dong Wu; Jing-Yu Zhu; Lang Gao; Yan-Yan Liu; Teng-Fei Yin
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 3.  Gut microbiota imbalance and colorectal cancer.

Authors:  Johan Gagnière; Jennifer Raisch; Julie Veziant; Nicolas Barnich; Richard Bonnet; Emmanuel Buc; Marie-Agnès Bringer; Denis Pezet; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 4.  Helicobacter pylori and colorectal neoplasia: Is there a causal link?

Authors:  Vasilios Papastergiou; Stylianos Karatapanis; Sotirios D Georgopoulos
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

5.  Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?

Authors:  Nam Hee Kim; Jung Ho Park; Dong Il Park; Chong Il Sohn; Yoon Suk Jung
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

6.  Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain.

Authors:  Nerea Fernández de Larrea-Baz; Angelika Michel; Beatriz Romero; Beatriz Pérez-Gómez; Victor Moreno; Vicente Martín; Trinidad Dierssen-Sotos; José J Jiménez-Moleón; Jesús Castilla; Adonina Tardón; Irune Ruiz; Rosana Peiró; Antonio Tejada; María D Chirlaque; Julia A Butt; Rocío Olmedo-Requena; Inés Gómez-Acebo; Pedro Linares; Elena Boldo; Antoni Castells; Michael Pawlita; Gemma Castaño-Vinyals; Manolis Kogevinas; Silvia de Sanjosé; Marina Pollán; Rosa Del Campo; Tim Waterboer; Nuria Aragonés
Journal:  Front Microbiol       Date:  2017-05-29       Impact factor: 5.640

Review 7.  Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.

Authors:  Somayeh Jahani-Sherafat; Masoud Alebouyeh; Sharareh Moghim; Hamed Ahmadi Amoli; Hajieh Ghasemian-Safaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

Review 8.  Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?

Authors:  Samira Tarashi; Seyed Davar Siadat; Sara Ahmadi Badi; Mohammadreza Zali; Roberto Biassoni; Mirco Ponzoni; Arfa Moshiri
Journal:  Microorganisms       Date:  2019-11-13

9.  Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis.

Authors:  Da Sol Choi; Seung In Seo; Woon Geon Shin; Chan Hyuk Park
Journal:  Clin Transl Gastroenterol       Date:  2020-02       Impact factor: 4.396

Review 10.  "Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer.

Authors:  Marion Avril; R William DePaolo
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.